Skeletal muscle oxidative capacity in amyotrophic lateral sclerosis

Terence E. Ryan, Melissa L. Erickson, Ajay Verma, Juan Chavez, Michael H. Rivner, Kevin K. Mccully

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Introduction: Mitochondrial dysfunction in the motor neuron has been suspected in amyotrophic lateral sclerosis (ALS). If mitochondrial abnormalities are also found in skeletal muscle, assessing skeletal muscle could serve as an important biomarker of disease progression. Methods: Using 31P magnetic resonance (31P-MRS) and near infrared (NIRS) spectroscopy, we compared the absolute values and reproducibility of skeletal muscle oxidative capacity in people with ALS (n=6) and healthy adults (young, n=7 and age-matched, n=4). Results: ALS patients had slower time constants for phosphocreatine (PCr) and muscle oxygen consumption (mVO2) compared with young, but not age-matched controls. The coefficient of variation for the time constant was 10% (SD=2.8%) and 17% (SD=6.2%) for PCr and mVO2, respectively. Conclusions: People with ALS had, on average, a small but not statistically significant, impairment in skeletal muscle mitochondrial function measured by both 31P-MRS and NIRS. Both methods demonstrated good reproducibility.

Original languageEnglish (US)
Pages (from-to)767-774
Number of pages8
JournalMuscle and Nerve
Volume50
Issue number5
DOIs
StatePublished - Nov 1 2014

Fingerprint

Amyotrophic Lateral Sclerosis
Skeletal Muscle
Phosphocreatine
Magnetic Resonance Spectroscopy
Near-Infrared Spectroscopy
Motor Neurons
Oxygen Consumption
Disease Progression
Young Adult
Biomarkers
Muscles

Keywords

  • MRS
  • Mitochondrial bioenergetics
  • Mitochondrial function
  • Motor neuron disease
  • NIRS

ASJC Scopus subject areas

  • Physiology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Physiology (medical)

Cite this

Ryan, T. E., Erickson, M. L., Verma, A., Chavez, J., Rivner, M. H., & Mccully, K. K. (2014). Skeletal muscle oxidative capacity in amyotrophic lateral sclerosis. Muscle and Nerve, 50(5), 767-774. https://doi.org/10.1002/mus.24223

Skeletal muscle oxidative capacity in amyotrophic lateral sclerosis. / Ryan, Terence E.; Erickson, Melissa L.; Verma, Ajay; Chavez, Juan; Rivner, Michael H.; Mccully, Kevin K.

In: Muscle and Nerve, Vol. 50, No. 5, 01.11.2014, p. 767-774.

Research output: Contribution to journalArticle

Ryan, TE, Erickson, ML, Verma, A, Chavez, J, Rivner, MH & Mccully, KK 2014, 'Skeletal muscle oxidative capacity in amyotrophic lateral sclerosis', Muscle and Nerve, vol. 50, no. 5, pp. 767-774. https://doi.org/10.1002/mus.24223
Ryan, Terence E. ; Erickson, Melissa L. ; Verma, Ajay ; Chavez, Juan ; Rivner, Michael H. ; Mccully, Kevin K. / Skeletal muscle oxidative capacity in amyotrophic lateral sclerosis. In: Muscle and Nerve. 2014 ; Vol. 50, No. 5. pp. 767-774.
@article{1df817653d1d434fb6372673ba7c6a4e,
title = "Skeletal muscle oxidative capacity in amyotrophic lateral sclerosis",
abstract = "Introduction: Mitochondrial dysfunction in the motor neuron has been suspected in amyotrophic lateral sclerosis (ALS). If mitochondrial abnormalities are also found in skeletal muscle, assessing skeletal muscle could serve as an important biomarker of disease progression. Methods: Using 31P magnetic resonance (31P-MRS) and near infrared (NIRS) spectroscopy, we compared the absolute values and reproducibility of skeletal muscle oxidative capacity in people with ALS (n=6) and healthy adults (young, n=7 and age-matched, n=4). Results: ALS patients had slower time constants for phosphocreatine (PCr) and muscle oxygen consumption (mVO2) compared with young, but not age-matched controls. The coefficient of variation for the time constant was 10{\%} (SD=2.8{\%}) and 17{\%} (SD=6.2{\%}) for PCr and mVO2, respectively. Conclusions: People with ALS had, on average, a small but not statistically significant, impairment in skeletal muscle mitochondrial function measured by both 31P-MRS and NIRS. Both methods demonstrated good reproducibility.",
keywords = "MRS, Mitochondrial bioenergetics, Mitochondrial function, Motor neuron disease, NIRS",
author = "Ryan, {Terence E.} and Erickson, {Melissa L.} and Ajay Verma and Juan Chavez and Rivner, {Michael H.} and Mccully, {Kevin K.}",
year = "2014",
month = "11",
day = "1",
doi = "10.1002/mus.24223",
language = "English (US)",
volume = "50",
pages = "767--774",
journal = "Muscle and Nerve",
issn = "0148-639X",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Skeletal muscle oxidative capacity in amyotrophic lateral sclerosis

AU - Ryan, Terence E.

AU - Erickson, Melissa L.

AU - Verma, Ajay

AU - Chavez, Juan

AU - Rivner, Michael H.

AU - Mccully, Kevin K.

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Introduction: Mitochondrial dysfunction in the motor neuron has been suspected in amyotrophic lateral sclerosis (ALS). If mitochondrial abnormalities are also found in skeletal muscle, assessing skeletal muscle could serve as an important biomarker of disease progression. Methods: Using 31P magnetic resonance (31P-MRS) and near infrared (NIRS) spectroscopy, we compared the absolute values and reproducibility of skeletal muscle oxidative capacity in people with ALS (n=6) and healthy adults (young, n=7 and age-matched, n=4). Results: ALS patients had slower time constants for phosphocreatine (PCr) and muscle oxygen consumption (mVO2) compared with young, but not age-matched controls. The coefficient of variation for the time constant was 10% (SD=2.8%) and 17% (SD=6.2%) for PCr and mVO2, respectively. Conclusions: People with ALS had, on average, a small but not statistically significant, impairment in skeletal muscle mitochondrial function measured by both 31P-MRS and NIRS. Both methods demonstrated good reproducibility.

AB - Introduction: Mitochondrial dysfunction in the motor neuron has been suspected in amyotrophic lateral sclerosis (ALS). If mitochondrial abnormalities are also found in skeletal muscle, assessing skeletal muscle could serve as an important biomarker of disease progression. Methods: Using 31P magnetic resonance (31P-MRS) and near infrared (NIRS) spectroscopy, we compared the absolute values and reproducibility of skeletal muscle oxidative capacity in people with ALS (n=6) and healthy adults (young, n=7 and age-matched, n=4). Results: ALS patients had slower time constants for phosphocreatine (PCr) and muscle oxygen consumption (mVO2) compared with young, but not age-matched controls. The coefficient of variation for the time constant was 10% (SD=2.8%) and 17% (SD=6.2%) for PCr and mVO2, respectively. Conclusions: People with ALS had, on average, a small but not statistically significant, impairment in skeletal muscle mitochondrial function measured by both 31P-MRS and NIRS. Both methods demonstrated good reproducibility.

KW - MRS

KW - Mitochondrial bioenergetics

KW - Mitochondrial function

KW - Motor neuron disease

KW - NIRS

UR - http://www.scopus.com/inward/record.url?scp=84921987094&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921987094&partnerID=8YFLogxK

U2 - 10.1002/mus.24223

DO - 10.1002/mus.24223

M3 - Article

VL - 50

SP - 767

EP - 774

JO - Muscle and Nerve

JF - Muscle and Nerve

SN - 0148-639X

IS - 5

ER -